DMK Pharma Lands $3.2M Deal To Sell Drug In Ch. 11

By Emlyn Cameron · May 6, 2024, 5:34 PM EDT

Drugmaker DMK Pharmaceuticals Corp. informed a Delaware bankruptcy judge Monday that the debtor worked out a tentative agreement in its Chapter 11 case to sell an opioid overdose recovery treatment for...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

DMK Pharmaceuticals has applied for Chapter 11 protection in Delaware, citing recent clinical trial failures and product recalls, as well as the government's allegation that a subsidiary engaged in criminal activities, as reasons for seeking bankruptcy relief.

Case Number

24-10153

Judge

Mary F. Walrath

Venue

U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

$13.9M

View Full Scorecard

Documents

Related Sections

Case Information

Case Title

DMK Pharmaceuticals Corporation

Case Number

24-10153

Court

Delaware

Nature of Suit

Date Filed

February 02, 2024

Recent Articles By Emlyn